Tscan Therapeutics Inc (TCRX) Stock Price, Quote & News

Company Profile

TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT) is in Phase I clinical trial, as...

Industry: Biotechnology

Sector: Healthcare

Phone: 857 399 9500

Website: www.tscan.com

Address:

830 Winter Street, Waltham, United States

DanishViking92 Jul. 11 at 6:29 PM

$TCRX It looks like it made a cup and handle on the 1y chart! Last time i spotted this pattern on $SKYE it moved up more than +200%!! Hold for $6 is my best advice, dont get fooled and sell too early - patience is key!

0 · Reply

14kmaker Jul. 11 at 4:43 PM

$TCRX not selling!

1 · Reply

mhaven2020 Jul. 11 at 1:32 PM

$HAIN should be a nice win today. $LYRA $SRFM $TCRX. Our analysis software is pretty cool. It saves market movers daily, so i have a list of daily market movers. There are 13 that have been in market movers for two weeks now. CURR, LIXT, $MBIO, MPU, ARTL, METC, EGG, KNW, SRFM, VOR, WOLF, NEGG, and RYET. Probably flipping one of those today. Our trade alerts get you 4 stocks sent daily that are early. No tickers that already made their move. Hit up the website and catalog to sign up.

1 · Reply

Schiellerup Jul. 11 at 9:37 AM

$TCRX $1.84 held nicely yesterday- Give us another green tick today 🔥

0 · Reply

DanishViking92 Jul. 10 at 8:50 PM

$TCRX no reason to sell this one for less than $6 - its quite obvious where we are heading!

0 · Reply

Spacey30 Jul. 10 at 7:34 PM

$TCRX like what I see here. Just made some decent profit on $RANI, and $VRT the last two days. Parking it here for a couple of days and expect to see the gains continue.

0 · Reply

mhaven2020 Jul. 10 at 5:44 PM

$HAIN $SRFM $TCRX $HOTH snag some $HAIN before the next move up. Join the tickers tip list from our website. Go to the catalog and sign up for Trade Commando tips. Membership gets 4 tickers per day that should be around 2 days before a nice move.

0 · Reply

juliio101 Jul. 10 at 11:53 AM

$TCRX all these pharma companies are like 300% plus in one day after catalyst. I believe we are next . The question is when.

1 · Reply

Schiellerup Jul. 10 at 10:36 AM

$TCRX time to cross the $2 today!

1 · Reply

Schiellerup Jul. 9 at 10:11 PM

$TCRX this will pump hard in the future

1 · Reply

TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference

May 6, 2025, 7:00 AM EDT - 2 months ago

TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Apr 28, 2025, 4:53 PM EDT - 2 months ago

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting

Mar 31, 2025, 7:00 AM EDT - 3 months ago

TScan Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 27, 2025, 7:00 AM EDT - 3 months ago

TScan Therapeutics Appoints Commercial Leader Stephen Camiolo as Senior Vice President, Market Access

Mar 7, 2025, 11:31 AM EST - 4 months ago

TScan: 2 Major Milestones Of TSC-101 To Carry Tide In 2025

Mar 5, 2025, 7:00 AM EST - 4 months ago

TScan Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 27, 2025, 7:00 AM EST - 4 months ago

TScan Therapeutics Announces Upcoming Presentation at the TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 7:00 AM EST - 5 months ago

TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Feb 10, 2025, 3:14 AM EST - 5 months ago

TScan Therapeutics: Finding Their Footing After An Eventful ASH Meeting

Dec 26, 2024, 7:00 AM EST - 7 months ago

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

Dec 23, 2024, 7:00 AM EST - 7 months ago

TScan Therapeutics Refinances Existing Convertible Debt Facility with Term Loan for up to $52.5 Million from Silicon Valley Bank

Dec 9, 2024, 5:45 PM EST - 7 months ago

TScan Therapeutics to Present Updated Data from the Ongoing ALLOHA™ Phase 1 Heme Trial During Oral Session at the 66th American Society of Hematology Annual Meeting and Exposition

Dec 5, 2024, 8:00 AM EST - 7 months ago

TScan Therapeutics Named a Top Place to Work by The Boston Globe for Three Consecutive Years

Dec 2, 2024, 7:00 AM EST - 7 months ago

TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Heme Development Strategy

Nov 5, 2024, 9:15 AM EST - 8 months ago

TScan Therapeutics Announces Upcoming Oral Presentation of Data from the ALLOHA™ Phase 1 Heme Trial at the 66th American Society of Hematology Annual Meeting and Exposition

Oct 4, 2024, 9:05 AM EDT - 10 months ago

TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting

Aug 29, 2024, 7:00 AM EDT - 11 months ago

TScan Therapeutics to Participate in Upcoming Investor Conferences

Aug 26, 2024, 10:09 AM EDT - 11 months ago

TScan Therapeutics: Speculative Buy With Near-Term Catalysts In Oncology

Aug 12, 2024, 7:00 AM EDT - 11 months ago

TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Jun 14, 2024, 7:00 AM EDT - 1 year ago

TScan Therapeutics Announces Updates to its Board of Directors

May 29, 2024, 7:00 AM EDT - 1 year ago

TScan Therapeutics Receives FDA's Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies

May 13, 2024, 7:00 AM EDT - 1 year ago

TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 9, 2024, 7:00 AM EDT - 1 year ago

TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors

Apr 24, 2024, 4:05 PM EDT - 1 year ago

TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting

Apr 24, 2024, 11:03 AM EDT - 1 year ago

TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares

Apr 22, 2024, 5:01 PM EDT - 1 year ago

TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting

Apr 19, 2024, 10:05 AM EDT - 1 year ago

TScan Therapeutics Announces Closing of Upsized Public Offering

Apr 17, 2024, 12:30 AM EDT - 1 year ago

TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering

Apr 16, 2024, 4:25 PM EDT - 1 year ago

TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering

Apr 16, 2024, 4:01 PM EDT - 1 year ago

TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities

Apr 8, 2024, 8:00 AM EDT - 1 year ago

TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D.

Apr 2, 2024, 7:00 AM EDT - 1 year ago

TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Mar 6, 2024, 7:00 AM EST - 1 year ago

TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Feb 28, 2024, 7:00 AM EST - 1 year ago

TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

Feb 26, 2024, 7:00 AM EST - 1 year ago

TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR

Feb 14, 2024, 7:00 AM EST - 1 year ago

TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR

Feb 6, 2024, 7:00 AM EST - 1 year ago

TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development

Jan 29, 2024, 7:00 AM EST - 1 year ago

TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer

Jan 18, 2024, 7:00 AM EST - 1 year ago

TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR

Jan 4, 2024, 7:00 AM EST - 1 year ago

TScan Therapeutics Announces 2024 Clinical Plans and Highlights Recent Progress

Dec 27, 2023, 7:00 PM EST - 1 year ago

TScan: Two 2024 TCR-T Data Readouts Could Bring Significant Value

Dec 9, 2023, 12:00 PM EST - 1 year ago

TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition

Dec 7, 2023, 7:00 AM EST - 1 year ago

TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations

Dec 4, 2023, 4:05 PM EST - 1 year ago

TScan Therapeutics to Host Virtual KOL Event to Discuss Results from Ongoing Phase 1 Trial of TSC-100 and TSC-101 Presented at the 65th ASH Annual Meeting and Exposition

Dec 4, 2023, 7:00 AM EST - 1 year ago

TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer

Nov 30, 2023, 7:00 AM EST - 1 year ago

TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years

Nov 9, 2023, 7:00 AM EST - 1 year ago

TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 6, 2023, 7:00 AM EST - 1 year ago

TScan Therapeutics Presents Phase 1 Trial Design for Solid Tumor Program at the Society for Immunotherapy of Cancer 38th Annual Meeting

Nov 2, 2023, 9:05 AM EDT - 1 year ago

TScan Therapeutics Announces Upcoming Presentation at the 65th American Society of Hematology Annual Meeting and Exposition

DanishViking92 Jul. 11 at 6:29 PM

0 · Reply

14kmaker Jul. 11 at 4:43 PM

$TCRX not selling!

1 · Reply

mhaven2020 Jul. 11 at 1:32 PM

1 · Reply

Schiellerup Jul. 11 at 9:37 AM

$TCRX $1.84 held nicely yesterday- Give us another green tick today 🔥

0 · Reply

DanishViking92 Jul. 10 at 8:50 PM

$TCRX no reason to sell this one for less than $6 - its quite obvious where we are heading!

0 · Reply

Spacey30 Jul. 10 at 7:34 PM

$TCRX like what I see here. Just made some decent profit on $RANI, and $VRT the last two days. Parking it here for a couple of days and expect to see the gains continue.

0 · Reply

mhaven2020 Jul. 10 at 5:44 PM

0 · Reply

juliio101 Jul. 10 at 11:53 AM

$TCRX all these pharma companies are like 300% plus in one day after catalyst. I believe we are next . The question is when.

1 · Reply

Schiellerup Jul. 10 at 10:36 AM

$TCRX time to cross the $2 today!

1 · Reply

Schiellerup Jul. 9 at 10:11 PM

$TCRX this will pump hard in the future

1 · Reply

14kmaker Jul. 9 at 9:06 PM

$TCRX just wait ‘til retail traders find this one…easy double

0 · Reply

mhaven2020 Jul. 9 at 5:34 PM

$HAIN should be stepping up anyday now. Thought it was today. Oh well, hopeful for Friday @ 1.95. $CLNE $SRFM $HOTH. My scanner is targeting multi day runners who are about to begin a run. So far it has been pretty spot on. Got heavy in here today. Usually, I'm in for a few days. These should be starting to hit in a few days. Usually 4ish days from the alert. I won't be dropping these for very long. The ticker tip line is in development. GLTA! Happy hunting! Videos soon! $TCRX

1 · Reply

juliio101 Jul. 9 at 3:10 PM

$TCRX $HAIN $HOTH $CLNE good luck :)

0 · Reply

mhaven2020 Jul. 9 at 2:09 PM

$TCRX locked some profits here. Dumped into $HAIN, $HOTH and $CLNE

0 · Reply

Schiellerup Jul. 9 at 1:52 PM

$TCRX F*****g send it boys!

0 · Reply

juliio101 Jul. 9 at 4:02 AM

$TCRX something good is coming up i think. On overnight its up 5%

1 · Reply

DanishViking92 Jul. 9 at 12:40 AM

$TCRX Insiders bought more than they sold aswell during the last 12 months = Bullish!! They know its very undervalued and that they are going to announce a bunch of great news during this 2H 2025! 💸

0 · Reply

DanishViking92 Jul. 9 at 12:36 AM

$TCRX Institutional ownership has increased a lot in last quarter = very bullish signal!

0 · Reply

ExplosiveGainz Jul. 9 at 12:21 AM

$TCRX reversal

0 · Reply

Schiellerup Jul. 8 at 10:07 PM

$TCRX looks like the board slowly wakens up

0 · Reply

DanishViking92 Jul. 8 at 9:47 PM

$SKYE $TCRX up +17% today!

0 · Reply

mhaven2020 Jul. 8 at 7:24 PM

$SRFM love that. Chalk up another win. $TCRX $LYRA. Jumped pretty heavy into $CLNE and $HOTH for a little bit. Looking for 20% on each ticker.

0 · Reply

Market Cap	104.13M
Revenue (ttm)	2.82M
Net Income (ttm)	-127.50M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-4,521.28%
Debt to Equity Ratio	0.15

Volume	228,600
Avg Vol	643,466
Day's Range	N/A - N/A
Shares Out	56.59M
Stochastic %K	82%
Beta	0.97
Analysts	Strong Sell
Price Target	$9.00